<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
14783-954-02
</NDCCode>
<PackageDescription>
1 BOX in 1 KIT (14783-954-02) > 1 KIT in 1 BOX (14783-954-01) * 9 g in 1 CASE (14783-949-01) * 9 g in 1 CASE (14783-952-01) * 9 g in 1 CASE (14783-951-01) * 9 g in 1 CASE (14783-950-01) * 9 g in 1 CASE (14783-953-01) * 9 g in 1 CASE (14783-947-01) * 9 g in 1 CASE (14783-946-01) * 9 g in 1 CASE (14783-945-01) * 9 g in 1 CASE (14783-948-01)
</PackageDescription>
<NDC11Code>
14783-0954-02
</NDC11Code>
<ProductNDC>
14783-954
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Lbel Clarite Clarifying Effect Foundation Spf 30
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Octinoxate, Oxybenzone, And Zinc Oxide
</NonProprietaryName>
<DosageFormName>
KIT
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20160606
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part352
</ApplicationNumber>
<LabelerName>
Ventura International LTD
</LabelerName>
<SubstanceName/>
<StrengthNumber/>
<StrengthUnit/>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-09-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20181231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>